Vitiligo often has a profound impact on patients' self-esteem and mental well-being, particularly when it affects visible areas such as the face or hands. Managing their expectations regarding treatment outcomes can be challenging, as some may anticipate complete repigmentation, which is not always attainable.
This common depigmenting skin disorder is also associated with a number of comorbidities, including autoimmune thyroiditis, alopecia areata, pernicious anemia, diabetes mellitus, hypoacusis, Addison’s disease, and celiac disease.
At Dermatology Week 2024, we’re dedicating an in-depth session to targeted therapies for vitiligo and strategies to improve patient's quality of life. Learn more here: https://okt.to/bCTr3n